Heparin is a generic designation for a heterogeneous mixture of highly sulfated glycosaminoglycans (GAGs) with a strong negative surface charge containing alternating D-glucosamine and hexuronic acid residues. Most heparin preparations do not contain a single chemical species, but rather consist of a mixture of molecules that vary in size. Pharmaceutical-grade heparin contains polysaccharide chains with molecular weights of 5 kDa to 40 kDa. In addition, such heparin chains exhibit structural heterogeneity in that there is variation in the extent of their sulfation or acetylation, or both. A number of these sulfate moieties have been shown to be essential for mediating heparin binding to the plasma protein antithrombin, 1 Summary: This study characterized heparin isolated from tuna skins. Glycosaminoglycans were isolated from tuna skin after digestion using anion exchange resin. Heparin was eluted from the resin by sodium chloride gradient and was further fractionated by acetone fractionation. Anticoagulant activity was determined using the activated partial thromboplastin time and Heptest assays. Potency was determined using amidolytic antifactor IIa and antifactor Xa assays. The presence of heparin in the extracted tuna skin glycosaminoglycans was confirmed using 13 C-nuclear magnetic resonance. The activated partial thromboplastin time and Heptest clotting times were doubled at concentrations of about 4 and 1 µg/mL, respectively. The clotting time prolongation and antiprotease activity induced by tuna heparin was readily neutralized by 25 µg/mL protamine sulfate. These results demonstrate that biologically active heparin with properties similar to clinical grade heparin can be derived from tuna skin, a raw material with otherwise relatively little economic value. Key Words: heparin-anticoagulant-fish skin the tissue using alkaline hydrolysis and proteolytic enzymes. The crude heparin is separated from the digested tissue using anion exchange resins and is subsequently eluted and treated to remove any impurities, such as residual proteins, nucleotides, or viruses, before recovery of the final product. The yield of heparin from porcine intestinal mucosa is approximately 35,000 units per animal. 6 Because of its complex structure and the limited knowledge on the structure-function relationship in heparin, the chemical synthesis of biologically active heparin polysaccharides has been limited. 7 In mammals, heparin is synthesized by mast cells and is therefore widely present throughout a variety of organs, including the liver, heart, lungs, kidneys, and intestine. 8 Isolation techniques similar to those used to make porcine heparin have shown that heparin is present in a number of marine species, including shrimp heads 9,10 and a variety of mollusks. [11] [12] [13] [14] The biologic role of heparin in these species is unknown, but once these heparins are isolated, they display biologic activities similar to those of porcine mucosal heparin. 11 Studies in the late 1960s and early 1970s showed that skin from rats and hogs contains heparin. 15, 16 A variety of GAGs, such as keratan sulfate, [17] [18] [19] chondroitin sulfates, 20 dermatan sulfate, 21 and acid mucopolysaccharides, 22 have been identified in the skin of various species of fish. Highly sulfated GAGs extracted from the skin of commercially caught, edible fish have previously been shown to exhibit potent anticoagulant activity. 23 The objective of this study was to demonstrate that heparin, exhibiting anticoagulant and antithrombotic properties, could be isolated from tuna skin.
MATERIALS AND METHODS

Isolation of Fish Skin Heparin
Skins were removed from freshly caught tuna by steaming. The removed tuna skins were preserved by the addition of 1.5% (w/w) sodium bisulfite and were shipped frozen. The tuna skins were thawed and then chopped. The chopped skins were diluted in water to make a 10% slurry. The pH of the solution was raised to approximately 10 by the addition of a 10% solution of sodium hydroxide. After 1 hour, sodium chloride was added to achieve a concentration of 2%, followed by the addition of a nonspecific protease.
After an overnight digestion, the mixture was sieved to remove the scales, and the ion exchange resin was added. The resin was removed after 12 hours and washed thoroughly with warm water until all nondigested material had been removed. A warm, 16% sodium chloride solution was used to elute the GAGs from the resin. Heparin was precipitated from the eluate by addition of 1.5 volumes of alcohol. The precipitate was filtered and dried.
Acetone fractionation, as outlined by Dietrich et al, 10 was used for further purification. Crude GAG extract (50 mg) was dissolved in 1 mL of 0.15 M sodium chloride. After centrifugation, acetone (400 µL) was added to the supernatant. The resulting solution was kept at 5°C for 24 hours. The precipitate that formed was collected and dried. The operation was repeated, successively adding increasing volumes of acetone (0.5, 0.6, 0.7, 1.0 volumes).
Electrophoresis of Tuna Skin Glycosaminoglycans
The crude GAG extracts were analyzed using agarose gel electrophoresis in a discontinuous barium acetate/1,3-diaminopropane acetate buffer as previously described. 24 
Nuclear Magnetic Resonance Analysis of Glycosaminoglycans
A 400-MHz Varian spectrometer (Palo Alto, Calif) was used to obtain 13 C-nuclear magnetic resonance (NMR) spectra of crude tuna skin GAGs.
Molecular Weight Determination by Gel Permeation Chromatography-High Performance Liquid Chromatography
The molecular weight profile of the tuna heparin fractions was determined using gel permeation chromatography as previously described. 25 Samples were dissolved at a concentration of 10 mg/mL in 0.2 M sodium sulfate (pH, 5.0). Samples were analyzed using a high-performance liquid chromatography system (Waters, Milford, Mass), in which 20 µL of each sample was injected onto TSK G3000SW and TSK G2000SW columns linked in tandem (TosoHaas, Montgomeryville, Pa). The 0.2 M sodium sulfate mobile phase was pumped at a steady rate of 0.5 mL/min. The elution profile was determined using refractive index and UV (234 nm) detectors. Molecular weights were calculated in relation to 19 narrow-range heparin calibrators using the Millenium-32 chromatography software (Waters).
Potency Analysis of Tuna Skin Heparin
Tuna heparin was supplemented to normal human plasma for the determination of antifactor Xa activity, and 25 µL of supplemented plasma was added to 200 µL of buffer (50 mM Tris, 175 mM sodium chloride, 7.5 mM ethylenediaminetetraacetic acid; pH, 8.4 ) and incubated at 37°C for 2 minutes. Then, 200 µL of 4 nkat/mL factor Xa (Enzyme Research Laboratories, South Bend, Ind) were added, and the solution was incubated for 1 minute. A total of 200 µL of 1 mM Spectrozyme Xa (American Diagnostica, Stamford, Conn) was added, and the reaction was incubated for exactly 5 minutes. The reaction was stopped by addition of 200 µL of glacial acetic acid.
Optical density at 405 nm was determined using a BioTek model EL311 microtiter plate reader (Winooski, Vt). For the determination of antifactor IIa activity, human thrombin (10 U/mL, Enzyme Research Laboratories) and Spectrozyme TH (1 mM) replaced the factor Xa and Spectrozyme Xa, respectively.
Potency of the tuna heparin fractions was determined in relation to the K5 heparin standard (US Pharmacopoeia, Rockville, Md) by using the sloperatio method.
Anticoagulant Activity of Tuna Skin Heparin
Anticoagulant activity was determined by measuring the activated partial thromboplastin time (aPTT) and the Heptest (Haemachem, St Louis, Mo) of normal human plasma supplemented with tuna skin heparin or porcine mucosal heparin. All clotting times were measured using a fibrometer (BBL, Cockeysville, Md). The aPTT was measured by incubating 100 µL of test plasma with 100 µL of Platelin L aPTT reagent (BioMerieux, Durham, NC) for 5 minutes at 37°C. Clotting time was measured after the addition of 100 µL of 0.025 M calcium chloride. The Heptest measure was done by incubating 100 µL of test plasma with 100 µL of bovine factor Xa reagent (Haemachem) for 2 minutes. Clotting time was measured after the addition of 100 µL Recalmix (Haemochem).
Neutralization of Anticoagulant Activity by Protamine Sulfate
Protamine sulfate, at a final concentration of 25 µg/mL, or saline, was added to normal human plasma supplemented with tuna heparin or porcine mucosal heparin. The aPTT and Heptest clotting times were determined, as described above.
RESULTS
Methodology similar to that used to extract commercial heparin was used to isolate crude GAG fractions from the skins of grouper, catfish, trout, cod, and tuna. The anticoagulant activity of these GAGs was compared with that of porcine heparin and dermatan sulfate using the aPTT and Heptest assays. As expected, heparin produced a more potent anticoagulant activity compared with dermatan sulfate. The GAGs from several species of fish also exhibited a measurable anticoagulant activity. Most potent in both the aPTT and Heptest assays were the GAGs obtained from tuna skin (Figure 1) .
The presence of heparin in the extracted fish GAGs was identified by 13 C-NMR ( Figure 2 ). Three key peaks in the NMR spectrum (starred) are indicative of the presence of heparin. 26 The peak with a chemical shift of approximately 61 ppm is that of glucosamine C-2-NSO 3 , the peak with a chemical shift of approximately 100 ppm is that of glucosamine NSO 3 6SO 3 , and the third peak with a chemical shift of approximately 102 ppm is that of iduronic acid C-1-2SO 3. The same peaks, although with lower intensity, were also observed in the NMR spectra of GAGs extracted from cod and grouper (data not shown).
Because of these results, tuna skin was used as a starting material for all subsequent studies. Analysis of the nonpurified GAG extracts by agarose gel electrophoresis in barbital buffer indicates that most of the GAG obtained from fish skin is either dermatan or chondroitin sulfate, with a small amount of heparin ( Figure 3, lane 2) .
The tuna skin extracts were purified by acetone fractionation. As seen in Figure 4 , the fractions that precipitated with 0.55 and 0.65 volumes of acetone contained relatively pure heparin as assessed by gel electrophoresis. Densitometry indicated that the dermatan sulfate contamination of these fractions was approximately 10%. The 0.55 and 0.65 volume fractions differed in the relative amounts of fast-moving and slow-moving heparin. Although fraction 0.55 contained only 35% of the total heparin in the sample, more than half was slow-moving heparin, whereas only 12% of fraction 0.65 was slow-moving heparin. The total amount of fast-moving and slow-moving heparin in the purified tuna material (fractions 0.55 and 0.65 combined) was 73% and 27%, respectively. A commercially available porcine heparin (lane 2) contained a similar proportion of fast-moving (71%) and slow-moving (29%) species.
Analysis of the purified tuna heparin using gel permeation chromatography-high performance liquid chromatography indicated a mean molecular weight of 12.3 kDa, comparable with the molecular weight expected for clinical-grade porcine heparin.
The biologic activity of tuna heparin in terms of its ability to inhibit key coagulation enzymes (factor Xa and thrombin) and its ability to prolong plasma-clotting times was determined. Relative to the USP K5 heparin standard, fractions 0.55 and 0.65 exhibited antifactor Xa potencies of 47 and 72 U/mg, respectively, and antithrombin potencies of 66 and 111 U/mg, respectively ( Figure 5 ).
Both tuna heparin fractions were observed to concentration-dependently prolong clotting times in the aPTT and Heptest assays ( Figure 6 ). Approximately a 2-fold higher concentration of tuna heparin was required to achieve a comparable prolongation of clotting time as measured by the aPTT, and 3-fold more tuna heparin was required to achieve a comparable prolongation of clotting time as measured by the Heptest. The addition of protamine sulfate (25 µg/mL) to plasma containing either tuna skin heparin or porcine mucosal heparin readily neutralized the anticoagulant activity as measured by the aPTT (Figure 7) or the Heptest (data not shown).
DISCUSSION
Porcine intestinal mucosa is the most common source of clinical-grade heparin. Compendial-grade unfractionated porcine mucosal heparins have equal antifactor Xa and antifactor IIa potencies of approximately 160 IU/mg and a mean molecular weight of approximately 15 kDa. Heparin has been isolated from a number of different species. [9] [10] [11] [13] [14] [15] [16] 27, 28 Although similar to the standard porcine mucosal heparin, heparins from other species also exhibit a number of distinct differences. Heparin isolated from mollusk, for example, has a relatively high mean molecular weight (22.5 kDa), an antifactor Xa/antifactor IIa ratio of less than 1, and contains up to 3 antithrombin binding sites per chain. 11 In contrast, heparin isolated from shrimp heads has a mean molecular weight of less than 10 kDa, an antifactor Xa/antifactor IIa ratio exceeding 1, and a potency of 95 IU/mg. 10 Heparin isolated from camel intestine had a higher mean molecular weight compared with porcine heparin, but its degree of sulfation was one third lower, with a corresponding reduction in antifactor Xa potency. 27 Fish skins appear to be a viable source of GAGs with anticoagulant activity. 23 Previous work examining GAGs obtained from a variety of edible species of fish has shown that GAGs from some species (grouper, cod, and tuna) contain a degree of sulfation comparable with that of porcine heparin. Also observed was that the GAGs with the highest degree of sulfation exhibited the most potent anticoagulant activity and were most able to promote HCII and antithrombin-mediated antithrombin activity.
CONCLUSIONS
This is the first report to demonstrate that antic oagulant activity of fish skin GAGs is associated with the presence of heparin. Electrophoretic analysis of the fish skin GAGs demonstrated that most of the GAG content consisted of dermatan and chondroitin sulfates. However, the identification of peaks associated with N-sulfated glucosamine and 2-O sulfated iduronic acid in the 13 C-NMR spectrum of the unpurified tuna skin GAGs suggested that a minor heparin-like component was present in the mixture. Neither of the glucosamine peaks would be expected to be present in samples containing pure dermatan sulfate, in which galactosamine replaces glucosamine.
Chondroitin sulfates, which are composed of nonsulfated glucuronic acid and acetylated galactosamine residues, would also be an unlikely source of such peaks.
Acetone fractionation of the crude tuna GAGs produced a heparin with a purity of approximately 90%. Analysis of this purified tuna heparin indicated that it is comparable with commercial porcine mucosal products in its molecular weight and distribution of fast-moving and slow-moving components. Slow-moving heparin is higher in molecular weight and is rich in trisulfated disaccharides, whereas fast-moving heparin tends to be lower in molecular weight and contains less sulfation. The higher molecular weight and more highly sulfated material would be expected to exhibit more anticoagulant activity.
Despite the physical similarities, biologic potency of the tuna heparin was somewhat less than that observed for typical commercial products. The tuna heparin exhibited a weighted average potency of 63 anti-Xa U/mg and 95 anti-IIa U/mg. Differences in the total amount of sulfation or the relative abundance of the minimal antithrombin binding sequence in the heparin chains may account for lower potency of tuna heparin compared with porcine heparin. Previous work by other groups characterizing heparins obtained from various mollusk species has demonstrated species-dependent variability in potency and structure. 28 It is also possible that this difference in potency may be related to the extent of purification. 28 The higher amount of antithrombin activity compared with antifactor Xa activity observed with the tuna heparin fractions may be due to the residual dermatan sulfate contamination, because dermatan sulfate preferentially inhibits thrombin via HCII.
Both fractions exhibited in vitro anticoagulant activity as measured by the prolongation of the activated partial thromboplastin time and Heptest clotting time. In each case, addition of protamine sulfate neutralized the anticoagulant activity.
The data from this study indicate that heparin makes up a small fraction of the GAGs present in tuna skin. Once purified, tuna skin heparin exhibits biologic actions similar to heparins obtained from more traditional sources. It will be interesting to determine similarities and differences among heparins isolated from additional species of fish.
